GSK (LON:GSK) Price Target Increased to GBX 1,660 by Analysts at JPMorgan Chase & Co.

GSK (LON:GSK – Free Report) had its target price increased by JPMorgan Chase & Co. from GBX 1,530 ($19.22) to GBX 1,660 ($20.85) in a research note issued to investors on Thursday morning, MarketBeat Ratings reports. They currently have an underweight rating on the stock. A number of other research firms have also recently weighed […]

Related Keywords

United Kingdom ,United States ,Emma Walmsley ,Urs Rohner ,Barclays ,Berenberg Bank ,Jpmorgan Chase Co ,Deutsche Bank Aktiengesellschaft ,Free Report ,Marketbeat Ratings ,Bank Aktiengesellschaft ,Get Free Report ,Commercial Operations ,Gsk ,Lon Gsk ,Medical ,Boost Price Target ,